Similarly, inhibition of EGLN1 has been shown to provide protection against atherosclerosis in mice by improving glucose and lipid metabolism and reducing inflammation and decreasing the areas of atherosclerotic plaque [86]. Here, EGLN1 is linked to atherosclerosis.